Skip to main content
SpringerLink
Log in

Im Fokus: Inflammatorische Kardiomyopathie

  • Leserbriefe
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Aretz HT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18: 619–624

    PubMed  Google Scholar 

  2. Basso C, Calabrese F, Corrado D, Thiene G (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50: 290–300

    Article  PubMed  Google Scholar 

  3. Baughman KL (2006) Diagnosis of myocarditis: death of Dallas criteria. Circulation 113: 593–595

    Article  PubMed  Google Scholar 

  4. Cooper LT, Virmani R, Chapman NM et al. (2006) National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc 81: 199–204

    PubMed  Google Scholar 

  5. D’Ambrosio A, Patti G, Manzoli A et al. (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85: 499–504

    Article  PubMed  Google Scholar 

  6. Felix SB, Staudt A, Dorffel WV et al. (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35: 1590–1598

    Article  PubMed  Google Scholar 

  7. Frustaci A, Chimenti C, Calabrese F et al. (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107: 857–863

    Article  PubMed  Google Scholar 

  8. Fujioka S, Kitaura Y, Ukimura A et al. (2000) Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36: 1920–1926

    Article  PubMed  Google Scholar 

  9. Grogan M, Redfield MM, Bailey KR et al. (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26: 80–84

    Article  PubMed  Google Scholar 

  10. Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64: 1235–1245

    PubMed  Google Scholar 

  11. Knebel F, Bohm M, Staudt A et al. (2004) Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 97: 517–520

    Article  PubMed  Google Scholar 

  12. Kuhl U, Schultheiss HP (1995) Treatment of chronic myocarditis with corticosteroids. Eur Heart J 16: 168–172

    PubMed  Google Scholar 

  13. Kuhl U, Pauschinger M, Schwimmbeck PL et al. (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793–2798

    Article  PubMed  Google Scholar 

  14. Kuhl U, Pauschinger M, Seeberg B et al. (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965–1270

    Article  PubMed  Google Scholar 

  15. Magnani JW, Dec GW (2006) Myocarditis: current trends in diagnosis and treatment. Circulation 113: 876–890

    Article  PubMed  Google Scholar 

  16. Maisch B, Camerini F, Schultheiss HP (1995) Immunosuppressive therapy for myocarditis. N Engl J Med 333: 1713–1714

    Article  Google Scholar 

  17. Maron BJ, Towbin JA, Thiene G et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807–1016

    Article  PubMed  Google Scholar 

  18. Mason JW, O’Connell JB, Herskowitz A et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333: 269–275

    Article  PubMed  Google Scholar 

  19. Richardson P, McKenna W, Bristow M et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841–842

    PubMed  Google Scholar 

  20. Schimke I, Muller J, Priem F et al. (2001) Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 38: 178–183

    Article  PubMed  Google Scholar 

  21. Shanes JG, Ghali J, Billingham ME et al. (1987) Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75: 401–405

    PubMed  Google Scholar 

  22. Staudt A, Schaper F, Stangl V et al. (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103: 2681–2686

    PubMed  Google Scholar 

  23. Terasaki F, Okabe M, Hayashi T et al. (1999) Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy: light microscopic, immunohistochemical, and virological analyses of myocardium specimens obtained by partial left ventriculectomy. J Card Surg 14: 141–146

    PubMed  Google Scholar 

  24. Why HJ, Meany BT, Richardson PJ et al. (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89: 2582–2589

    PubMed  Google Scholar 

  25. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy : two-year follow-up results. Circulation 104: 39–45

    PubMed  Google Scholar 

Download references

Author information

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

. Im Fokus: Inflammatorische Kardiomyopathie. Internist 47, 970–973 (2006). https://doi.org/10.1007/s00108-006-1699-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-006-1699-3

Search

Navigation